Table 2. Medication Use During Follow-up Among Patients With Nonvalvular Atrial Fibrillation Taking a NOAC.
| Medication | NOAC Users, No. (%) (n = 91 330) |
| Aspirin | 70 228 (76.89) |
| Rivaroxaban | 54 006 (59.13) |
| Nonsteroid anti-inflammatory drugs | 49 886 (54.62) |
| Atorvastatin | 48 666 (53.29) |
| Dabigatran | 45 347 (49.65) |
| Diltiazem | 40 934 (44.82) |
| Clopidogrel | 38 483 (42.14) |
| Amiodarone | 37 737 (41.32) |
| Antihypertensive | 34 075 (37.31) |
| Digoxin | 33 181 (36.33) |
| Proton pump inhibitors | 29 244 (32.02) |
| Glucocorticoids | 26 382 (28.89) |
| Warfarin | 25 427 (27.84) |
| Insulin | 25 313 (27.72) |
| Lipid-lowering agents | 18 985 (20.79) |
| Apixaban | 12 886 (14.11) |
| Erythromycin or clarithromycin | 12 878 (14.10) |
| Hypoglycemic agents | 11 943 (13.08) |
| Ticlopidine | 10 233 (11.20) |
| Verapamil | 9246 (10.12) |
| Dronedarone | 6033 (6.61) |
| Phenytoin | 4816 (5.27) |
| Ticagrelor | 3902 (4.27) |
| Fluconazole | 2477 (2.71) |
| Other azolesa | 1174 (1.29) |
| Rifampin | 1151 (1.26) |
| Cyclosporine | 567 (0.62) |
Abbreviation: NOAC, non–vitamin K oral anticoagulant.
a
Other azoles include ketoconazole, itraconazole, voriconazole, or posaconazole.